Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed: 20,548
Companies: 1,769
Drugs tracked: 4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources

Quick answer

Fibre mixture

Fluoxetine

Folic acid

Fruit Bar

Galantamine

Generic cetrorelix acetate

Goal2Quit + NRT Sampling

Green Tea Extract

Guselkumab

HCV+PWID

HLA-B*5801 test

High Hyaluronic Acid concentrations (0.5 mg/ml)

Hydroxychloroquine Sulfate 200 MG [Plaquenil]

IMIQUIMOD cream 50mg/g

Intestinal Microbiota Transplant (IMT) Capsules

Intravenous Nicotine

Ipilimumab

Kuvan

LCAR-M61S cells preparation

Lactobacillus rhamnosus F-1

Lidocaine IV

Liquid Biopsy (SPOT-MAS Assay)

Liquid Biopsy Early Screening

Low strength nicotine e-liquid

Frequently asked questions